MIRA
INFORM REPORT
|
Report Date : |
22.02.2012 |
IDENTIFICATION DETAILS
|
Name : |
SHANGHAI SCIENCE BIOTECHNOLOGY CO., LTD. |
|
|
|
|
Registered Office : |
Room 213, Block 5, No. 1288 Yecheng Road, Jiading District
Shanghai 201800 Pr |
|
|
|
|
Country : |
China |
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Date of Incorporation : |
25.02.2008 |
|
|
|
|
Com. Reg. No.: |
310114001857020 |
|
|
|
|
Legal Form : |
Limited Liabilities Company |
|
|
|
|
Line of Business : |
Technology development, technology consulting, technology services, and technology transfer of pharmaceutical intermediates; selling pharmaceutical intermediates; importing and exporting goods and technology. |
|
|
|
|
No. of Employees : |
5 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 20,000 |
|
Status : |
Small Company |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
China |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name and address
SHANGHAI SCIENCE BIOTECHNOLOGY CO., LTD.
ROOM 213, BLOCK 5, NO. 1288 YECHENG ROAD, JIADING DISTRICT
SHANGHAI 201800 PR CHINA
TEL: 86 (0) 21-59909001
FAX: 86 (0) 21-59909028
EXECUTIVE SUMMARY
Date of Registration : february 25, 2008
REGISTRATION NO. : 310114001857020
LEGAL FORM : Limited liabilities company
REGISTERED CAPITAL : cny 500,000
staff :
5
BUSINESS CATEGORY : trading
Revenue :
CNY 28,435,000 (AS OF DEC. 31, 2011)
EQUITIES :
CNY 1,875,000 (AS OF DEC. 31, 2011)
WEBSITE : N/A
E-MAIL :
N/A
PAYMENT :
AVERAGE
Recommended Credit Limit : UP TO USD 20,000
MARKET CONDITION : average
FINANCIAL CONDITION : stable
OPERATIONAL TREN D : ORDINARY
GENERAL REPUTATION : AVERAGE
EXCHANGE RATE :
CNY 6.30 = USD 1
Adopted abbreviations (as follows)
SC - Subject Company
(the company inquired by you)
N/A – Not available
CNY – China Yuan Ren
Min Bi
OPERATIONAL TREND & GENERAL
REPUTATION
This section aims at indicating the relative positions of SC in respect
of its operational trend & general reputation
Operational Trend:- General
Reputation:-
Upward Excellent
Steady Good
Fairly Steady Fairly
Good
Ordinary Average
Fair Fair
Stagnant Detrimental
Downward Not
known
Not known Not
yet be determined
Not yet be determined
LEGAL STATUS & HISTORY
SC was established
as a limited liabilities company of PRC with State Administration of Industry
& Commerce (SAIC) under registration No.: 310114001857020 on February 25, 2008.
SC’s Organization Code Certificate No.:
67119735-0
SC’s registered capital: cny 500,000
SC’s paid-in capital: cny 500,000
Registration Change Record:
No significant changes of SC have been noted
in SAIC since its incorporation.
Current Co search indicates SC’s shareholders & chief executives are
as follows:-
|
Name of Shareholder (s) |
% of Shareholding |
|
Qu Yuling |
50 |
|
Zhang Liangwei |
50 |
SC’s Chief Executives:-
|
Position |
Name |
|
Legal Representative, Chairman, and
General Manager |
Qu Yuling |
|
Supervisor |
Zhang Liangwei |
RECENT DEVELOPMENT
No recent development was found during our checks at present.
SHAREHOLDER CHART &
BACKGROUND
Name %
of Shareholding
Qu Yuling 50
Zhang Liangwei 50
MANAGEMENT
Qu Yuling , Legal Representative,
Chairman and General Manager
--------------------------------------------------------------------------------------------------
Ø
Gender: F
Ø
Qualification:
University
Ø
Working
experience (s):
From 2008
to present, working in SC as legal representative, chairman and general manager
Zhang Liangwei ,
Supervisor
------------------------------------------------
Ø
Gender: M
Ø
Qualification:
University
BUSINESS OPERATION
SC’s registered business scope includes technology
development, technology consulting, technology services, and technology
transfer of pharmaceutical intermediates; selling pharmaceutical intermediates;
importing
and exporting goods and technology.
SC is mainly
engaged in selling pharmaceutical intermediates.
SC’s products
mainly include:
5-Hydroxypentanoic
acid cyclohexylamide
Glycyl-L-phenylalanine
2-Benzyl
acrylic acid
Glycyl-L-glutamine
Glycyl-L-glycine
Thiamine
propyl disulfide
Allithiamine
Bisbentiamine
Etc.
SC sources its materials 100% from domestic
market. SC sells 100% of its products to overseas market, mainly Southeast
Asia, Middle East, etc.
The buying terms
of SC include T/T and Credit of 30-60 days. The payment terms of SC include
T/T, L/C and Credit of 30-60 days.
Staff & Office:
--------------------------
SC is known
to have approx. 5 staff at
present.
SC rents an area
as its operating office of approx. 80 sq. meters at the heading address.
RELATED COMPANY
SC
is not known to have any subsidiary at present.
PAYMENT
Overall payment appraisal:
( ) Excellent ( ) Good (X) Average ( ) Fair ( ) Poor ( ) Not yet be determined
The appraisal serves as a reference to reveal SC's payments habits and
ability to pay. It is based on the 3
weighed factors: Trade payment experience (through current enquiry with SC's
suppliers), our delinquent payment and our debt collection record concerning
SC.
Trade payment experience: SC did not
provide any name of trade/service suppliers and we have no other sources to conduct
the enquiry at present.
Delinquent payment record: None in our
database.
Debt collection record: No overdue amount
owed by SC was placed to us for collection within the last 6 years.
BANKING
Basic Bank:
Bank
of Communications Shanghai Branch Jiading Sub-branch
AC#:
310069079018010043214
FINANCIALS
Balance Sheet
|
Unit: CNY’000 |
As
of Dec. 31, 2011 |
|
2,031 |
|
|
Accounts
receivable |
603 |
|
Advances to
suppliers |
0 |
|
Other receivable |
0 |
|
Inventory |
248 |
|
Non-current assets
within one year |
0 |
|
Other current
assets |
690 |
|
|
------------------ |
|
Current assets |
3,572 |
|
Fixed assets |
0 |
|
Construction in
progress |
0 |
|
Deferred income
tax assets |
0 |
|
Other
non-current assets |
0 |
|
|
------------------ |
|
Total assets |
3,572 |
|
|
============= |
|
Short-term loans |
0 |
|
Notes payable |
0 |
|
Accounts payable |
1,511 |
|
Wages payable |
0 |
|
Taxes payable |
67 |
|
Advances from
clients |
117 |
|
Other payable |
2 |
|
Other current
liabilities |
0 |
|
|
------------------ |
|
Current
liabilities |
1,697 |
|
Non-current
liabilities |
0 |
|
|
------------------ |
|
Total
liabilities |
1,697 |
|
Equities |
1,875 |
|
|
------------------ |
|
Total
liabilities & equities |
3,572 |
|
|
============= |
Income Statement
|
Unit: CNY’000 |
As of Dec. 31,
2011 |
|
Revenue |
28,435 |
|
Cost of sales |
26,019 |
|
Taxes and surcharges |
36 |
|
Sales expense |
96 |
|
Management expense |
448 |
|
Finance expense |
-16 |
|
Profit before
tax |
924 |
|
Less: profit tax |
207 |
|
717 |
Important Ratios
=============
|
|
As
of Dec. 31, 2011 |
|
*Current ratio |
2.10 |
|
*Quick ratio |
1.96 |
|
*Liabilities
to assets |
0.48 |
|
*Net profit
margin (%) |
2.52 |
|
*Return on
total assets (%) |
20.07 |
|
*Inventory /
Revenue ×365 |
4 days |
|
*Accounts
receivable/ Revenue ×365 |
8 days |
|
*
Revenue/Total assets |
7.96 |
|
* Cost of
sales / Revenue |
0.92 |
FINANCIAL COMMENTS
PROFITABILITY:
AVERAGE
l
The revenue of SC appears average in its line.
l
SC’s net profit margin is average.
l
SC’s return on total assets is fairly good.
l
SC’s cost of sales is fairly high, comparing with
its revenue.
LIQUIDITY: FAIRLY
GOOD
l
The current ratio of SC is maintained in a fairly
good level.
l
SC’s quick ratio is maintained in a fairly good
level.
l
The inventory of SC is maintained in an average
level.
l
The accounts receivable of SC is maintained in an
average level.
l
SC has no short-term loans in 2011.
l
SC’s revenue is in a fairly good level, comparing
with the size of its total assets.
LEVERAGE: AVERAGE
l
The debt ratio of SC is average.
l
The risk for SC to go bankrupt is above average.
Overall financial
condition of the SC: Stable.
CONCLUSIONS
SC is considered small-sized in its line with stable financial
conditions. A credit line up to USD 20,000
would appear to be within SC’s capacities.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.49.08 |
|
|
1 |
Rs.77.80 |
|
Euro |
1 |
Rs.65.17 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any risk
and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its
officials.